enVVeno Medical Corp (Nasdaq: NVNO), an SEC filer in Surgical & Medical Instruments & Apparatus, closed at $10.75, -4.4%, on 2026-08-28, with a market cap of $8M as of 2026-08-27 and a return on equity of -56.2%. Institutional ownership, earnings history and filed financials are on the tabs below.
Returns use ADJUSTED closes (splits + dividends).
Volume as VALUE TRADED — close × volume, in USD.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | NVNO | SPY | Δ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 · ytd | +7.8% | −16.2% | +1.3% | +3.1% | +8.5% | −5.5% | −1.0% | +1.4% | — | — | — | — | −2.9% | +13.4% | −16.3pp |
| 2025 | +8.9% | −3.3% | −17.3% | +14.1% | +20.3% | +10.5% | +15.5% | −82.7% | +13.3% | −22.2% | −45.6% | −16.3% | −89.4% | +17.7% | −107.1pp |
| 2024 | −16.1% | +44.5% | −12.7% | −2.6% | −10.0% | +10.1% | +2.5% | −2.2% | −36.1% | +0.3% | −7.7% | −2.9% | −41.2% | +24.9% | −66.1pp |
| 2023 | +10.4% | +3.0% | −19.3% | −13.4% | −28.2% | +5.8% | +59.7% | +0.6% | +8.9% | −18.4% | −21.4% | +48.6% | +0.8% | +26.2% | −25.4pp |
| 2022 | −16.4% | −8.5% | +26.4% | −29.4% | −9.1% | −7.6% | +39.9% | +39.9% | −15.1% | +0.2% | −6.2% | −13.6% | −22.6% | −18.2% | −4.4pp |
| 2021 · part | — | — | — | — | — | — | — | — | — | — | −24.0% | −1.6% | −25.3% | +28.7% | −54.0pp |
Month-end over prior month-end; a blank cell is no return.
Basis. Both columns share one basis, so Δ is like-for-like.
End-of-day closes; a “ytd” or “part” year is not a full year.
| Month | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ⓘ | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 |
| Positive ⓘ | 60% | 40% | 40% | 40% | 40% | 60% | 80% | 60% | 50% | 50% | 0% | 20% |
| Median | +7.8% | −3.3% | −12.7% | −2.6% | −9.1% | +5.8% | +15.5% | +0.6% | −3.1% | −9.1% | −21.4% | −2.9% |
| Best | +10.4% | +44.5% | +26.4% | +14.1% | +20.3% | +10.5% | +59.7% | +39.9% | +13.3% | +0.3% | −6.2% | +48.6% |
| Worst | −16.4% | −16.2% | −19.3% | −29.4% | −28.2% | −7.6% | −1.0% | −82.7% | −36.1% | −22.2% | −45.6% | −16.3% |
| vs SPY ⓘ | +4.1pp | −2.1pp | −11.7pp | −7.4pp | −9.3pp | +0.7pp | +13.2pp | −1.6pp | +1.9pp | −12.1pp | −23.2pp | −6.3pp |
58 monthly observations · 2021–2026 · benchmark SPY
